| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0090-4295(01)00945-1 |
| P698 | PubMed publication ID | 11337303 |
| P2093 | author name string | Bennett CJ | |
| Lewis R | |||
| Althof SE | |||
| Siegel RL | |||
| Stecher VJ | |||
| Borkon WD | |||
| Boykin WH | |||
| P2860 | cites work | Sexual dysfunction in the United States: prevalence and predictors | Q33852255 |
| Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group | Q34747116 | ||
| Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction | Q42679993 | ||
| Health outcomes variables important to patients in the treatment of erectile dysfunction | Q45110927 | ||
| The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. | Q50951063 | ||
| Construction of a surrogate variable for impotence in the Massachusetts Male Aging Study. | Q52378491 | ||
| Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects. | Q53346951 | ||
| On life satisfaction in male erectile dysfunction. | Q53589971 | ||
| NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence | Q56019307 | ||
| Nitric oxide in the penis: physiology and pathology | Q71927171 | ||
| EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction | Q77305048 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | erectile dysfunction | Q184674 |
| P304 | page(s) | 960-965 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Urology | Q7900884 |
| P1476 | title | Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire | |
| P478 | volume | 57 |
| Q47215244 | 'Sex for life'? Men's counter-stories on 'erectile dysfunction', male sexuality and ageing |
| Q44693716 | A classification based on peak systolic velocity and end diastolic velocity predicts sildenafil citrate success. |
| Q36214669 | A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient? |
| Q41945517 | A placebo-controlled, multicenter, randomized, double-blind, flexible-dose, two-way crossover study to evaluate the efficacy and safety of sildenafil in men with traumatic spinal cord injury and erectile dysfunction |
| Q44203531 | Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction |
| Q37119711 | An assessment of patient-reported outcomes for men with erectile dysfunction: Pfizer's perspective |
| Q46803480 | An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy |
| Q33672177 | Analysis of dyadic data: a guideline applied to erectile dysfunction |
| Q51267077 | Assessing satisfaction in men and their female partners after treatment with phosphodiesterase type 5 inhibitors for erectile dysfunction. |
| Q46916860 | Assessment of comparative treatment satisfaction with sildenafil citrate and penile injection therapy in patients responding to both |
| Q36307484 | Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction |
| Q36760036 | Correlations between increased erection hardness and improvements in emotional well-being and satisfaction outcomes in men treated with sildenafil citrate for erectile dysfunction |
| Q46005434 | Efficacy and safety of omega-3 for treatment of early-stage Peyronie's disease: A prospective, randomized, double-blind placebo-controlled study. |
| Q44499100 | Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial |
| Q46682506 | Efficacy, safety and tolerability of sildenafil in Brazilian hypertensive patients on multiple antihypertensive drugs |
| Q35779307 | Emerging oral drugs for erectile dysfunction |
| Q84462849 | Erectile dysfunction |
| Q93501227 | Erectile dysfunction |
| Q36608332 | Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra). |
| Q36608327 | Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction |
| Q25256846 | Indirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunction |
| Q36305415 | Inventories for male and female sexual dysfunctions |
| Q35167462 | Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up. |
| Q34592663 | Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction. |
| Q35569842 | New achievements and pharmacotherapeutic approaches to impotence in the elderly |
| Q44836379 | Partner responses to sildenafil citrate (Viagra) treatment of erectile dysfunction |
| Q33495987 | Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study |
| Q36154866 | Phosphodiesterase 5 inhibitors for erectile dysfunction |
| Q46500272 | Quality assurance in the urologist's practice. Erectile dysfunction as an example of a multicenter approach to documenting treatment results |
| Q43810732 | Relationship between patient self-assessment of erectile dysfunction and the sexual health inventory for men. |
| Q53429131 | Reliability and validity of the sexual life quality questionnaire (SLQQ). |
| Q79163707 | Research instruments for the diagnosis and treatment of patients with erectile dysfunction |
| Q34132004 | Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study. |
| Q42878965 | Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: a double-blind, placebo-controlled, randomized study |
| Q36523906 | Sildenafil citrate (Viagra) treatment for erectile dysfunction: An updated profile of response and effectiveness |
| Q37018954 | Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence |
| Q53233323 | Sildenafil reduces bother associated with erectile dysfunction: pooled analysis of five randomized, double-blind trials. |
| Q38113844 | Sildenafil: two decades of benefits or risks? |
| Q37024547 | The application of quantitative methods for identifying and exploring the presence of bias in systematic reviews: PDE-5 inhibitors for erectile dysfunction. |
| Q45239627 | The assessment of sexual functions in women with male partners complaining of erectile dysfunction: does treatment of male sexual dysfunction improve female partner's sexual functions? |
| Q45067630 | The female partner's satisfaction with sildenafil citrate treatment of erectile dysfunction |
| Q44244655 | Topical alprostadil cream for the treatment of erectile dysfunction: a combined analysis of the phase II program |
| Q37427312 | Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction |
| Q42615396 | Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E(1) intracavernosal injection therapy to oral sildenafil citrate |
| Q35750719 | Update on oral treatments for male erectile dysfunction |
| Q24792437 | Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease |
| Q37184189 | Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications. |
| Q91599501 | Veterans' Satisfaction With Erectile Dysfunction Treatment |
| Q83185161 | [Determining factors in patient satisfaction with erectile dysfunction treatment] |
Search more.